(Q39750666)
Statements
Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease (English)
Adam Smith
Brian Giunta
Michael Fountain
Jun Tan
R Douglas Shytle
18 January 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference